Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge.
Right Under Our Noses: Olfactory Pathology In Central Nervous System Demyelinating Diseases
Vitamin D-binding protein and vitamin D status of black Americans and white Americans.
Please mind the gap: axonal transport deficits in multiple sclerosis neurodegeneration.
Balance exercise for persons with multiple sclerosis using Wii games: a randomised, controlled multi-centre study.
Riluzole increases glutamate uptake by cultured C6 astroglial cells.
Low-contrast multifocal visual evoked potentials: Identifying more shades of gray in MS.
Perceived impact of spasticity is associated with spatial and temporal parameters of gait in multiple sclerosis.
Therapeutic protein-drug interaction assessment for daclizumab high-yield process in patients with multiple sclerosis using a cocktail approach.
Proceedings of the European Charcot Foundation Symposium A Reappraisal of Nutrition and Environment in Multiple Sclerosis, European Charcot Foundation Symposium, December 2-4, 2010, Fiuggi, Italy.
Transient gadolinium leakage in natalizumab-treated multiple sclerosis.
Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis.
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study.
Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review.
Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the boston area community health (BACH) survey.
[Physical rehabilitation in multiple sclerosis: general principles and high-tech approaches].
Smoking and Risk of Multiple Sclerosis: Evidence of Modification by NAT1 Variants.
[Unified assessment of adverse events of multiple sclerosis disease modifying drugs.]
In vitro assessment of the direct effect of laquinimod on basic functions of human neural stem cells and oligodendrocyte progenitor cells.
Validity and reliability of VO2-max measurements in persons with multiple sclerosis.
MRI characteristics of familial and sporadic multiple sclerosis patients.
Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
Solitary sclerosis: progressive myelopathy from solitary demyelinating lesion. A new entity?
Tumefactive demyelinating lesions during etanercept treatment requiring decompressive hemicraniectomy.
Therapy-related acute leukemia in two patients with multiple sclerosis treated with Mitoxantrone.
Pages
« first
‹ previous
…
158
159
160
161
162
163
164
165
166
…
next ›
last »